Article Details
Retrieved on: 2021-07-16 04:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
As at March 2021, Hansa Biopharma had cash of kr1.3b and no debt. In the last year, its cash burn was kr291m. Therefore, from March 2021 it had 4.3 ...
Article found on: simplywall.st
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here